Nicotinic acid and nicotinamide adenine dinucleotide (NAD) therapy in schizophrenia: a review.
D000208:Acute Disease; D000284:Administration, Oral; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D006801:Humans; D007275:Injections, Intravenous; D009243:NAD / Q000008:administration & dosage / Q000627:therapeutic use*; D009536:Niacinamide / Q000008:administration & dosage / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D010919:Placebos; D012075:Remission, Spontaneous; D012559:Schizophrenia / Q000188:drug therapy*
D009539:Nicotinic Acids; D010919:Placebos; D009243:NAD; D009536:Niacinamide